المؤلفون: Romero-Fernandez W; Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala Univesity, 75124, Uppsala, Sweden., Taura JJ; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.; Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, IDIBELL, L'Hospitalet de Llobregat, 08907, Barcelona, Spain., Crans RAJ; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.; Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, IDIBELL, L'Hospitalet de Llobregat, 08907, Barcelona, Spain., Lopez-Cano M; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat, 08907, Barcelona, Spain.; Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, IDIBELL, L'Hospitalet de Llobregat, 08907, Barcelona, Spain., Fores-Pons R; Division of Cellular and Molecular Neurochemistry, Department of Neuroscience, Karolinska Institutet, Biomedicum (B0851), Solnavägen 9, 17165, Stockholm, Sweden., Narváez M; Facultad de Medicina, Instituto de Investigación Biomédica de Málaga, Universidad de Málaga, Málaga, Spain., Carlsson J; Department of Cell and Molecular Biology, Science for Life Laboratory, Uppsala Univesity, 75124, Uppsala, Sweden., Ciruela F; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, School of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, L'Hospitalet de Llobregat, 08907, Barcelona, Spain. fciruela@ub.edu.; Neuropharmacology & Pain Group, Neuroscience Program, Bellvitge Institute for Biomedical Research, IDIBELL, L'Hospitalet de Llobregat, 08907, Barcelona, Spain. fciruela@ub.edu., Fuxe K; Division of Cellular and Molecular Neurochemistry, Department of Neuroscience, Karolinska Institutet, Biomedicum (B0851), Solnavägen 9, 17165, Stockholm, Sweden. Kjell.Fuxe@ki.se., Borroto-Escuela DO; Division of Cellular and Molecular Neurochemistry, Department of Neuroscience, Karolinska Institutet, Biomedicum (B0851), Solnavägen 9, 17165, Stockholm, Sweden. dasiel.borroto.escuela@ki.se.; Laboratory of Receptomics and brain disorders, Department of Human Physiology, Faculty of Medicine, University of Malaga, Calle Jiménez Fraud, 10, 29071, Malaga, Malaga, Spain. dasiel.borroto.escuela@ki.se.

المصدر: Molecular neurobiology [Mol Neurobiol] 2022 Oct; Vol. 59 (10), pp. 5955-5969. Date of Electronic Publication: 2022 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 8900963 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-1182 (Electronic) Linking ISSN: 08937648 NLM ISO Abbreviation: Mol Neurobiol Subsets: MEDLINE

مواضيع طبية MeSH: Dopamine* , Parkinson Disease*, Adenosine ; Animals ; Catalepsy ; HEK293 Cells ; Haloperidol ; Humans ; Mice ; Protein Subunits ; Rats ; Receptor, Adenosine A2A/metabolism ; Receptors, Dopamine D2/metabolism